INVESTIGATION OF THE EFFECTS OF BAPNE AND QI GONG EXERCISES ON BALANCE AND QUALITY OF LIFE IN INDIVIDUALS OVER 60
NCT06106217, Not applicable, Unknown, Istanbul Medipol University Hospital
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | INVESTIGATION OF THE EFFECTS OF BAPNE AND QI GONG EXERCISES ON BALANCE AND QUALITY OF LIFE IN INDIVIDUALS OVER 60 | ClinicalTrials.gov |
| NCT number | NCT06106217 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 57 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Istanbul Medipol University Hospital | ClinicalTrials.gov |
| Conditions | Biomechanics, Anatomy, Psychology, Neuroscience, Ethnomusicology Method, qi Gong, Quality of Life, Balance | ClinicalTrials.gov |
| Interventions | bapne, qi gong | ClinicalTrials.gov |
| First posted | 2023-10-30 | ClinicalTrials.gov |
| Last updated | 2023-11-28 | ClinicalTrials.gov |
Registered outcomes 13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Ithaki Fall Risk Questionnaire | 14 weeks | This developed scale consists of a total of 19 risk factors, including risk factors that may cause patient falls. Risk factors were categorized as major and minor, and minor risk factors were given 1 point and major risk factors were given 5 points. Two risk levels, low and high, were determined over the total score obtained as a result of the evaluation of risk factors. In order to distinguish high-risk patients and to take necessary precautions, it is envisaged to use the "Four Leaf Clover" figure in patients at high risk of falling. | ClinicalTrials.gov |
| Primary | Berg Balance Scale | 14 weeks | Berg balance scale is a valid, reliable and sensitive measurement method that measures functional balance. The test, which includes 14 functional tests and is completed in an average of 10-20 minutes, has a score between 0-4. At 0, the loss of balance is maximum, while at a value of 4, the patient is independent of balance. The maximum score of the test is 56, and the minimum score is 0. A high score indicates good functional balance. | ClinicalTrials.gov |
| Primary | Libra Balance Board | 14 weeks | Balance board produced by Easytech is a computer aided balance measuring device. This device measures 42x9x42 cm and weighs 2.7 kilograms. It gives a score out of 100, 0 points the best balance and 100 points the worst balance. | ClinicalTrials.gov |
| Primary | Pittsburgh Sleep Quality Index | 14 weeks | Buysse et al. It is a scale that defines good and bad sleep, developed by in 1989. A total of 24 questions, 19 of which are self-assessed, and 5 are answered by a roommate or spouse. These assess sleep duration, latency, and the frequency and severity of specific sleep-related problems. Evaluated with points between 0-3. | ClinicalTrials.gov |
| Primary | WHOQOL-old | 14 weeks | It consists of 24 questions translated into Turkish as the World Health Organization quality of life module for the elderly. Validity reliability Eser S. et al. module made by; autonomy, past present and future activities, social inheritance, death-death and intimacy. | ClinicalTrials.gov |
| Secondary | Demographic information | Baseline (only in the first evaluation) | Name, surname, date of birth, gender, address, education level of the participants who participated in the study were recorded. They were recorded in the demographic information form. | ClinicalTrials.gov |
| Secondary | Muscle Strength Rating | 14 weeks | Electronic myometer was used to evaluate muscle strength. Muscle strength was measured with a Jtech brand myometer. To hip flexors, extensors, abductors and adductors, knee extensors and flexors, ankle plantar and dorsi flexors, trunk extensors and abdominals, shoulder abductors, adductors, flexors and extensors, elbow flexors and extensors, wrist flexors and extensors, wrist flexor muscle and extensors will be applied. The muscle test will be performed on the dominant side for the extremities. | ClinicalTrials.gov |
| Secondary | 6 Minute Walk Test | 14 weeks | The 6-minute walk test is one of the tests that reflects functional performance. This test is carried out in a 30-meter corridor with the dimensions of 10x40 meters. Patients are asked to walk at the highest speed they can walk for 6 minutes, but without running. The patients are encouraged verbally before and during the walk and it is ensured that they do not lose their motivation. As a result of the test, blood pressure and heart rate values, how many meters they walked in 6 minutes are recorded. | ClinicalTrials.gov |
| Secondary | Beck Depression Scale | 14 weeks | It is a tool used to measure the severity of depression with 21 multiple-choice questions created by Aaron T. Beck and a Turkish version of the study. The symptoms of depression show up in our emotions and our bodies. Beck depression scale measures both of these factors, thus providing a more comprehensive and accurate diagnosis. | ClinicalTrials.gov |
| Secondary | Mini Mental Test | 14 weeks | First, Folstein et al. The test published by Molloy and Standish in 1997 and standardized by Güngen C. et al. Turkish validity and reliability study was conducted by It is a short, useful and standardized method that can be used to determine the cognitive level globally. | ClinicalTrials.gov |
| Secondary | Stroop Test | 14 weeks | It consists of 60 boxes with random red, blue and green colors and 60 randomly arranged words "red", "green" and "blue" with different ink colors and different colors. The test consists of three main tasks. The time to finish the test, the number of errors and the number of spontaneous corrections are calculated. It is a complex test that evaluates multiple frontal lobe functions. In the test, the ability to perceive, the speed of processing information in the face of misleading stimuli, and the ability of the person's perception system to direct with distracting stimuli are evaluated. | ClinicalTrials.gov |
| Secondary | Object Flip Test | 14 weeks | It is a test in which participants try to find the coin hidden in two blue and red glasses. If the coin is known correctly 12 times in a row, the experiment is terminated. Points are given according to the number of mistakes and a maximum of 50 repetitions can be done. The lowest score in this test indicates good OFT performance. | ClinicalTrials.gov |
| Secondary | Vocabulary Fluency Test | 14 weeks | It is a test that takes 3 minutes in total. Participants who are asked to produce as many words as possible with the letters F, A and S are given one minute for each letter. The total number of words produced is determined as a score. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 6
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)